See What HealthDay Can Do For You
Contact Us

ASTRO: Cholesterol Screening May Benefit Hodgkin's Patients

Screening and appropriate treatment with cholesterol-lowering drugs may extend survival

WEDNESDAY, Nov. 8 (HealthDay News) -- In patients with Hodgkin's disease, cholesterol screening and treatment with cholesterol-lowering drugs may help extend survival, according to research presented this week at the annual meeting of the American Society for Therapeutic Radiology and Oncology in Philadelphia.

Aileen Chen, M.D., of the Dana-Farber Cancer Institute in Boston, and colleagues studied a group of 25-year-old Hodgkin's survivors and compared outcomes in those who received lipid screening every five years starting five years after treatment with those who received no lipid screening.

The researchers found that patients who received lipid screening followed by statin therapy, when warranted, lived six months longer than those who received no lipid screening.

"Although physicians are aware that Hodgkin's lymphoma survivors are at increased risk of heart disease, it hasn't been well established how to best monitor these patients," Chen said in a statement. "Our study shows that lipid screening in Hodgkin's survivors is cost effective and provides physicians with a guideline on how frequently they should be screening for high cholesterol, an important risk factor for heart disease."


Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.